1. Home
  2. ERAS vs SGU Comparison

ERAS vs SGU Comparison

Compare ERAS & SGU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ERAS
  • SGU
  • Stock Information
  • Founded
  • ERAS 2018
  • SGU 1995
  • Country
  • ERAS United States
  • SGU United States
  • Employees
  • ERAS N/A
  • SGU N/A
  • Industry
  • ERAS Biotechnology: Pharmaceutical Preparations
  • SGU Other Specialty Stores
  • Sector
  • ERAS Health Care
  • SGU Consumer Discretionary
  • Exchange
  • ERAS Nasdaq
  • SGU Nasdaq
  • Market Cap
  • ERAS 484.4M
  • SGU 388.5M
  • IPO Year
  • ERAS 2021
  • SGU 1995
  • Fundamental
  • Price
  • ERAS $1.58
  • SGU $11.72
  • Analyst Decision
  • ERAS Strong Buy
  • SGU
  • Analyst Count
  • ERAS 6
  • SGU 0
  • Target Price
  • ERAS $4.50
  • SGU N/A
  • AVG Volume (30 Days)
  • ERAS 714.7K
  • SGU 53.0K
  • Earning Date
  • ERAS 08-12-2025
  • SGU 08-06-2025
  • Dividend Yield
  • ERAS N/A
  • SGU 6.28%
  • EPS Growth
  • ERAS N/A
  • SGU 33.71
  • EPS
  • ERAS N/A
  • SGU 1.66
  • Revenue
  • ERAS N/A
  • SGU $1,777,057,000.00
  • Revenue This Year
  • ERAS N/A
  • SGU N/A
  • Revenue Next Year
  • ERAS N/A
  • SGU N/A
  • P/E Ratio
  • ERAS N/A
  • SGU $7.05
  • Revenue Growth
  • ERAS N/A
  • SGU N/A
  • 52 Week Low
  • ERAS $1.01
  • SGU $10.84
  • 52 Week High
  • ERAS $3.31
  • SGU $13.75
  • Technical
  • Relative Strength Index (RSI)
  • ERAS 53.64
  • SGU 52.76
  • Support Level
  • ERAS $1.44
  • SGU $11.50
  • Resistance Level
  • ERAS $1.64
  • SGU $11.73
  • Average True Range (ATR)
  • ERAS 0.10
  • SGU 0.19
  • MACD
  • ERAS 0.01
  • SGU 0.02
  • Stochastic Oscillator
  • ERAS 61.54
  • SGU 73.81

About ERAS Erasca Inc.

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.

About SGU Star Group L.P.

Star Group LP is a company engaged in providing home heating products and services to residential and commercial customers. The company offers heating oil and air conditioning equipment, as well as home security and plumbing services. The company also sells diesel fuel, gasoline, and home heating oil. Geographically, the company operates in U.S.

Share on Social Networks: